← Back to headlines





Netherlands to Receive Experimental Hantavirus Drug
The Netherlands is set to be one of the first European countries to receive a portion of Favipiravir, an experimental drug against hantavirus, amid concerns over rising infections.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories

Prince Harry and Meghan Markle Return to the United Kingdom After Six Years Abroad
19m ago

Deadly Floods and Mudslides Strike Nepal-Tibet Border Region
23m ago
Ukrainian Drones Strike Major Warehouse of Russia’s Top E-Commerce Firm
26m ago

Lithuanian President Says He Was Informed of CIA Chief's Moscow Visit
30m ago